Question 1

What is the catalog number for Tissue FFPE Sections, Tendon?

Accepted Answer

The catalog number for Tissue FFPE Sections, Tendon is CS800792.

Question 2

What sizes are available for Tissue FFPE Sections, Tendon?

Accepted Answer

Tissue FFPE Sections, Tendon is available in the following size(s): 5x 5 µm.

Question 3

Is Tissue FFPE Sections, Tendon in stock?

Accepted Answer

Tissue FFPE Sections, Tendon is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Tissue FFPE Sections, Tendon?

Accepted Answer

The safety data sheet for Tissue FFPE Sections, Tendon is available here: https://cdn.origene.com/sds/cs800792.pdf.

Question 5

What is Tissue FFPE Sections, Tendon used for?

Accepted Answer

Tissue Sections (5x5um), FFPE; Tendon; Within normal limits

Question 6

Is antigen retrieval required for IHC with this antibody?

Accepted Answer

Recommended antigen retrieval methods, where applicable, are listed on the datasheet under the IHC protocol section.

Question 7

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 8

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Tissue FFPE Sections, Tendon

Product Specifications

Stability

Storage Conditions

Frequently Asked Questions

Explore Other Products

Dylight 649 Conjugated Succinyl Triticum vulgare Lectin (Wheat Germ), -Succinyl WGA-

CPT1B Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2A6]

Recombinant NGF Antibody

Recombinant NGF Antibody

Recombinant NGF Antibody

Myosin Light Chain 2 (MYL2) (1-166) Mouse Monoclonal Antibody [Clone ID: AT3B2]